Medicare covering GLP-1 weight loss drugs starting Jul. 1
Digest more
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.
Daily Mail on MSN
Thousands with liver disease set to be prescribed weight-loss jab Wegovy, says UK drugs watchdog
Weight loss medication can be prescribed to people battling liver disease under new guidelines announced today.
Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that’s approved by the U.S. Food and Drug Administration (FDA) for type 2 diabetes.
The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.
Five-ingredient dinners, easy lunches and a delicious meal-prep breakfast all in one weight-loss meal plan? Yes, please!
Contrave and phentermine are weight loss medications approved by the U.S. Food and Drug Administration (FDA) for adults with obesity or adults with overweight and a weight-related medical condition. Contrave targets the reward center of the brain to curb food cravings while phentermine suppresses appetite by increasing certain brain chemicals.
